Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
Core EBITDA Growth

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -27.6568.7394.61-11.1854.02

What is the latest Core EBITDA Growth ratio of NEULAND LABORATORIES ?

The latest Core EBITDA Growth ratio of NEULAND LABORATORIES is -27.65 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-27.65
Mar202468.73
Mar202394.61
Mar2022-11.18
Mar202154.02

How is Core EBITDA Growth of NEULAND LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 -27.65
Negative
Mar2024 68.73
-27.35
Mar2023 94.61
Positive
Mar2022 -11.18
Negative
Mar2021 54.02 -

Other Financial Ratios of NEULAND LABORATORIES


Compare Core EBITDA Growth ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹15,399.7 Cr -3% -4.9% 0.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,555.0 Cr -1.5% 1.6% 1.3% Stock Analytics
DIVIS LABORATORIES ₹159,889.0 Cr -2% -4.3% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,073.0 Cr -0.8% 0.5% 32% Stock Analytics
DR REDDYS LABORATORIES ₹105,133.0 Cr -2.7% -1.6% 6.9% Stock Analytics
CIPLA ₹98,492.9 Cr -3.9% -9.1% -18.4% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-3%

-4.9%

0.3%

SENSEX

-2.6%

-10.2%

-1.6%


You may also like the below Video Courses